Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 208,861,408
  • Shares Outstanding, K 6,830,000
  • Annual Sales, $ 67,325 M
  • Annual Income, $ 12,808 M
  • 60-Month Beta 0.39
  • Price/Sales N/A
  • Price/Cash Flow 9.85
  • Price/Book N/A
Trade RHHBY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 02/01/24
  • Annual Dividend & Yield 0.88 (2.86%)
  • Most Recent Dividend 0.875 on 03/14/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.0600 +0.57%
on 04/08/24
32.8000 -7.84%
on 03/20/24
-2.4100 (-7.38%)
since 03/15/24
3-Month
30.0600 +0.57%
on 04/08/24
36.2100 -16.51%
on 01/31/24
-6.0700 (-16.72%)
since 01/16/24
52-Week
30.0600 +0.57%
on 04/08/24
40.4800 -25.32%
on 06/05/23
-8.5000 (-21.95%)
since 04/14/23

Most Recent Stories

More News
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.

Think globally with this high-yielding ETF.

TM : 236.52 (-2.13%)
NVS : 93.20 (-1.28%)
HSBC : 39.65 (-2.27%)
SHEL : 71.06 (-1.22%)
RHHBY : 30.2300 (-1.14%)
VYMI : 66.16 (-1.46%)
Why Roche Holdings Stock Popped Today

Roche's new Alzheimer's test has a long road ahead of it, but it may help boost the pharmaceutical company's slow growth rate.

RHHBY : 30.2300 (-1.14%)
LLY : 746.74 (-0.54%)
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.

Recursion is playing the long game with its AI-focused approach to drug discovery and development.

RHHBY : 30.2300 (-1.14%)
RXRX : 7.57 (-2.82%)
Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024

Roche introduces its suite of navify operational excellence solutions, including navify Analytics and navify Monitoring, for use in laboratories and point of...

RHHBY : 30.2300 (-1.14%)
Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe

The renowned brokerage firm weighed in on its top stock picks from the European market, which could offer investors better value than the outsized GRANOLAS group of equities at current levels.

NVDA : 874.15 (+1.64%)
MSFT : 414.58 (+0.23%)
AMZN : 183.32 (-0.16%)
AAPL : 169.38 (-1.92%)
META : 499.76 (-0.09%)
GOOGL : 154.40 (-0.30%)
TSLA : 157.11 (-2.71%)
GS : 396.86 (-1.00%)
GSK : 39.95 (-1.36%)
RHHBY : 30.2300 (-1.14%)
NSRGY : 100.8300 (-0.12%)
NVS : 93.20 (-1.28%)
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

NetworkNewsWire Editorial Coverage : On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type...

LEXX : 2.3100 (+16.08%)
AMGN : 265.64 (+0.05%)
LLY : 746.74 (-0.54%)
RHHBY : 30.2300 (-1.14%)
WW : 1.5600 (-9.30%)
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

EQNX::TICKER_START (NASDAQ:LEXX),(NASDAQ:AMGN),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:WW) EQNX::TICKER_END

WW : 1.5600 (-9.30%)
LEXX : 2.3100 (+16.08%)
AMGN : 265.64 (+0.05%)
LLY : 746.74 (-0.54%)
RHHBY : 30.2300 (-1.14%)
2 Growth Stocks That Could Make You Richer in 2024 and Beyond

Last year wasn't great for either stock, but that's no reason to ignore them.

RHHBY : 30.2300 (-1.14%)
SRPT : 117.29 (-0.86%)
DXCM : 136.52 (+1.46%)
3 Great Foreign Companies to Invest in Right Now

These international companies can bring a helpful new flavor to your investment portfolio.

NVDA : 874.15 (+1.64%)
INTC : 36.26 (-0.14%)
AMD : 163.46 (+1.96%)
ASML : 976.92 (+2.31%)
RHHBY : 30.2300 (-1.14%)
TEAM : 194.85 (+1.57%)
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry

Which weight-loss stocks are good buys today?

GS : 396.86 (-1.00%)
LLY : 746.74 (-0.54%)
NVO : 123.45 (-0.36%)
PFE : 25.69 (-0.85%)
AZN : 68.26 (-0.68%)
RHHBY : 30.2300 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 31.0867
2nd Resistance Point 30.9533
1st Resistance Point 30.7667
Last Price 30.2300
1st Support Level 30.4467
2nd Support Level 30.3133
3rd Support Level 30.1267

See More

52-Week High 40.4800
Fibonacci 61.8% 36.4996
Fibonacci 50% 35.2700
Fibonacci 38.2% 34.0404
Last Price 30.2300
52-Week Low 30.0600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar